Company / Cost of Revenue
Globus Medical Cost of Revenue History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$957.8M
FY2025
5-year range
$180.0M / $1.0B
FY2021-FY2025
Trend
-7.5%
vs FY2024
Sector context
#50 of 113
Health Care
What the data says
At $958M, Globus Medical's cost of revenue ranks #64 of 113 in the Health Care sector. Cost of Revenue has fluctuated over the past 10 years, ranging from $111M in FY2016 to $1.0B in FY2024.
Based on SEC 10-K filings.
$958M in FY2025 with a 5-year CAGR of +43.1%.
Increased from $548M to $958M over the past 2 years.
Health Care sector context is included.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- +53.7%
- 5-Year CAGR
- +43.1%
- 10-Year CAGR
- -
Sector benchmark
#64 of 113 in Health CareTop 56% of 113This company $957.8M Sector average $11.3B
▼
-91.5% below sector average
Key checks
Key Insights
- 5-year CAGR of +43.1%, indicating consistent growth.
- In FY2025, cost of revenue decreased 7.5% year-over-year.
- Ranks #50 out of 113 companies in the Health Care sector.
- Peak cost of revenue was recorded in FY2024.
Company context
Key Data Points
- Altman Z-Score 3.91 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $957.8M | -7.5% |
| FY2024 | $1.0B | +88.9% |
| FY2023 | $548.2M | +107.9% |
| FY2022 | $263.7M | +46.5% |
| FY2021 | $180.0M | +12.9% |
| FY2020 | $159.4M | -11.4% |
| FY2019 | $180.0M | +33.6% |
| FY2018 | $134.7M | -10.5% |
| FY2017 | $150.5M | +35.8% |
| FY2016 | $110.8M | +10.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026